Rosetta Genomics
(OTC) ROSGQ
Rosetta Genomics Financials at a Glance
Market Cap
$600
Revenue (TTM)
$5.49M
Net Income (TTM)
$14.27M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-21.85 (Low)
Dividend
$0.00
Beta (Volatility)
-21.85 (Low)
Price
$0.00
Volume
21
Open
$0.00
Price
$0.00
Volume
21
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-21.85 (Low)
Price
$0.00
Volume
21
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
ROSGQ News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rosetta Genomics
ROSGQ Financials
Key Financial Metrics (TTM)
Gross Margin
19%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
0%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$600.00
Shares Outstanding
5.93M
Volume
21
Avg. Volume
78.667
Financials (TTM)
Gross Profit
$1.79M
Operating Income
$15.66M
EBITDA
$15.32M
Operating Cash Flow
$10.37M
Capital Expenditure
$223.00K
Free Cash Flow
$10.59M
Cash & ST Invst.
$6.16M
Total Debt
$3.79M
Rosetta Genomics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$870.00K
-66.6%
Gross Profit
$301.00K
-68.1%
Gross Margin
34.60%
N/A
Market Cap
$600.00
N/A
Market Cap/Employee
$6.98
N/A
Employees
86
N/A
Net Income
$2.07M
+48.7%
EBITDA
$1.37M
+65.8%
Quarterly Fundamentals
Net Cash
$1.12M
-109.4%
Accounts Receivable
$987.00K
-74.1%
Inventory
$0.00
N/A
Long Term Debt
$2.43M
N/A
Short Term Debt
$110.00K
N/A
Return on Assets
-1.36%
N/A
Return on Invested Capital
-1.92%
N/A
Free Cash Flow
$12.26M
N/A
Operating Cash Flow
$11.96M
N/A